Back to Results
First PageMeta Content
Medicine / Lactones / Merck / Pharmacology / Sterols / Cholesterol / Simvastatin / Lovastatin / Low-density lipoprotein / Chemistry / Statins / Organic chemistry


Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-Cholesterol Drugs Abe Dunn December 13, 2011 Abstract
Add to Reading List

Document Date: 2011-12-16 10:30:12


Open Document

File Size: 250,09 KB

Share Result on Facebook

Company

Heart Protection Study Collaboration Group / IMS Health / Users / /

Country

United States / United Kingdom / /

Currency

USD / /

IndustryTerm

treatment of high cholesterol / pharmaceutical sales estimates / drug insurance coverage / pharmaceuticals / pharmaceutical industry / insurance plan / health insurance / pharmaceutical sector / drug insurance / drug products / generic products / medical technology / /

MedicalCondition

disease / colorectal cancer / clinical heart disease / heart disease / muscle pain / high cholesterol / /

MedicalTreatment

drug therapy / /

Organization

World Health Organization / Bureau of Economic Analysis / Bureau of Labor Statistics / Centers for Disease Control and Prevention / /

Person

Brett Wendling / Ralph Bradley / Stephen Donald / John Greenlees / Randal Watson / Ken Hendricks / Karen Rasmussen / Ana Aizcorbe / Adam Shapiro / Chuck Romeo / Sarah Pack / /

Position

physician / representative / /

Product

Baycol / Vytorin / Pravachol / Simvastatin / Crestor / Lipitor / Mevacor / Lescol / Advicor / Zocor / /

SocialTag